Two Sigma Advisers
MGNX icon

Two Sigma Advisers’s MacroGenics MGNX Stock Holding History

Two Sigma Advisers’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,195,000
Closed -$1.92M – 1281
2025
Q4 		$1.92M Buy
1,195,000
+446,400
+60% +$702K ﹤0.01% 1207
2025
Q3 		$1.26M Sell
748,600
-108,500
-13% -$176K ﹤0.01% 1349
2025
Q2 		$1.04M Sell
857,100
-211,100
-20% -$306K ﹤0.01% 1426
2025
Q1 		$1.36M Sell
1,068,200
-50,400
-5% -$132K ﹤0.01% 1324
2024
Q4 		$3.64M Buy
1,118,600
+74,596
+7% +$269K 0.01% 843
2024
Q3 		$3.43M Sell
1,044,004
-107,396
-9% -$418K 0.01% 835
2024
Q2 		$4.89M Buy
+1,151,400
New +$11.2M 0.01% 765
2023
Q4 		– Sell
-93,900
Closed -$438K – 2588
2023
Q3 		$438K Sell
93,900
-476,200
-84% -$2.37M ﹤0.01% 1836
2023
Q2 		$3.05M Sell
570,100
-404,900
-42% -$2.5M 0.01% 985
2023
Q1 		$6.99M Sell
975,000
-163,200
-14% -$983K 0.02% 672
2022
Q4 		$7.64M Buy
1,138,200
+191,500
+20% +$1.05M 0.02% 596
2022
Q3 		$3.28M Sell
946,700
-73,500
-7% -$281K 0.01% 940
2022
Q2 		$3.01M Buy
1,020,200
+774,100
+315% +$4.07M 0.01% 1003
2022
Q1 		$2.17M Buy
246,100
+212,900
+641% +$2.35M 0.01% 1211
2021
Q4 		$533K Buy
33,200
+18,100
+120% +$341K ﹤0.01% 1884
2021
Q3 		$316K Sell
15,100
-136,500
-90% -$3.29M ﹤0.01% 2098
2021
Q2 		$4.07M Sell
151,600
-92,900
-38% -$2.72M 0.01% 951
2021
Q1 		$7.79M Sell
244,500
-80,500
-25% -$1.95M 0.02% 669
2020
Q4 		$7.43M Buy
325,000
+119,800
+58% +$2.76M 0.02% 674
2020
Q3 		$5.17M Sell
205,200
-3,800
-2% -$104K 0.01% 751
2020
Q2 		$5.83M Buy
209,000
+900
+0.4% +$15.6K 0.02% 740
2020
Q1 		$1.21M Buy
208,100
+13,000
+7% +$118K ﹤0.01% 1375
2019
Q4 		$2.12M Buy
+195,100
New +$1.93M ﹤0.01% 1203
2019
Q3 		– Sell
-17,700
Closed -$300K – 2330
2019
Q2 		$300K Buy
+17,700
New +$304K ﹤0.01% 2016
2018
Q3 		– Sell
-11,300
Closed -$233K – 2323
2018
Q2 		$233K Buy
+11,300
New +$255K ﹤0.01% 2170
2016
Q2 		– Sell
-19,200
Closed -$360K – 2138
2016
Q1 		$360K Buy
+19,200
New +$366K ﹤0.01% 1585
2015
Q1 		– Sell
-6,600
Closed -$231K – 2200
2014
Q4 		$231K Buy
+6,600
New +$165K ﹤0.01% 2124

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Two Sigma Advisers's MGNX Position: Q1 2026 in Review

Two Sigma Advisers sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 1,195,000 shares — an estimated $1.92M sold.

Two Sigma Advisers first reported a position in MGNX in Q4 2014 and held it in 27 quarters. The position peaked at $7.79M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Two Sigma Advisers reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,195,000 MacroGenics shares in Q1 2026, an estimated $1.92M.
  • Two Sigma Advisers first reported a position in MacroGenics in Q4 2014 and held it in 27 quarters.
  • Two Sigma Advisers's MacroGenics position peaked at $7.79M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.